227 related articles for article (PubMed ID: 31559473)
21. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
22. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
[TBL] [Abstract][Full Text] [Related]
23. Root of the superior mesenteric artery in pancreatitis and pancreatic carcinoma: evaluation with CT.
Schulte SJ; Baron RL; Freeny PC; Patten RM; Gorell HA; Maclin ML
Radiology; 1991 Sep; 180(3):659-62. PubMed ID: 1871275
[TBL] [Abstract][Full Text] [Related]
24. MRI evaluation of pancreatic ductal adenocarcinoma: diagnosis, mimics, and staging.
Bowman AW; Bolan CW
Abdom Radiol (NY); 2019 Mar; 44(3):936-949. PubMed ID: 29967986
[TBL] [Abstract][Full Text] [Related]
25. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma.
Gong XH; Xu JR; Qian LJ
Abdom Radiol (NY); 2021 Sep; 46(9):4226-4237. PubMed ID: 33914139
[TBL] [Abstract][Full Text] [Related]
26. Is there any clinical or radiologic feature as a preoperative marker for differentiating mass-forming pancreatitis from early-stage pancreatic adenocarcinoma?
Lee H; Lee JK; Kang SS; Choi D; Jang KT; Kim JH; Lee KT; Paik SW; Yoo BC; Rhee JC
Hepatogastroenterology; 2007; 54(79):2134-40. PubMed ID: 18251176
[TBL] [Abstract][Full Text] [Related]
27. Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma.
Kang JD; Clarke SE; Costa AF
Eur Radiol; 2021 Apr; 31(4):2422-2432. PubMed ID: 32997176
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case.
Krishnasamy R; Agarwal S; Singh S; Puri S; Sakhuja P; Agarwal AK
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):553-6. PubMed ID: 17897923
[TBL] [Abstract][Full Text] [Related]
30. A case of pancreatic carcinoma with marked ductal dilatation: what contributed to the dilatation?
Abe H; Kimura W; Maema A; Makuuchi M
Int J Pancreatol; 2000 Feb; 27(1):65-8. PubMed ID: 10811025
[TBL] [Abstract][Full Text] [Related]
31. Groove pancreatitis and how to differentiate it from pancreatic adenocarcinoma.
Berral Santana AM; Cedrún Sitges I
Radiologia (Engl Ed); 2023; 65(1):81-88. PubMed ID: 36842788
[TBL] [Abstract][Full Text] [Related]
32. [Radiological evaluation of pancreatic ductal adenocarcinoma].
Akai H; Otomo K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
[TBL] [Abstract][Full Text] [Related]
33. Author's reply: "ADC values from diffusion-weighted imaging may be lower for autoimmune pancreatitis than for pancreatic ductal adenocarcinoma".
Ha J; Kim DW; Choi SH
Dig Liver Dis; 2022 Jul; 54(7):994-995. PubMed ID: 35614006
[No Abstract] [Full Text] [Related]
34. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren S; Zhao R; Zhang J; Guo K; Gu X; Duan S; Wang Z; Chen R
Abdom Radiol (NY); 2020 May; 45(5):1524-1533. PubMed ID: 32279101
[TBL] [Abstract][Full Text] [Related]
35. Optimal target b-value on computed diffusion-weighted magnetic resonance imaging for visualization of pancreatic ductal adenocarcinoma and focal autoimmune pancreatitis.
Ichikawa S; Kromrey ML; Motosugi U; Onishi H
Abdom Radiol (NY); 2021 Feb; 46(2):636-646. PubMed ID: 32740865
[TBL] [Abstract][Full Text] [Related]
36. Paraduodenal pancreatitis: benign and malignant mimics at MRI.
Mittal PK; Harri P; Nandwana S; Moreno CC; Muraki T; Adsay V; Cox K; Pehlivanoglu B; Alexander LF; Chatterjee A; Miller FH
Abdom Radiol (NY); 2017 Nov; 42(11):2652-2674. PubMed ID: 28660333
[TBL] [Abstract][Full Text] [Related]
37. Differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma based on CT texture analysis.
Wang Z; Chen X; Wang J; Cui W; Ren S; Wang Z
Acta Radiol; 2020 May; 61(5):595-604. PubMed ID: 31522519
[No Abstract] [Full Text] [Related]
38. Differentiating a chronic hyperplastic mass from pancreatic cancer: a challenge remaining in multidetector CT of the pancreas.
Boll DT; Merkle EM
Eur Radiol; 2003 Dec; 13 Suppl 5():M42-9. PubMed ID: 14989611
[TBL] [Abstract][Full Text] [Related]
39. MRI of adenocarcinoma of the pancreas.
Miller FH; Rini NJ; Keppke AL
AJR Am J Roentgenol; 2006 Oct; 187(4):W365-74. PubMed ID: 16985107
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed Tomography.
E L; Xu Y; Wu Z; Li L; Zhang N; Yang H; Schwartz LH; Lu L; Zhao B
J Comput Assist Tomogr; 2020; 44(4):511-518. PubMed ID: 32697521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
